We are live on ! Find out more
Aberdeen Group

Aberdeen Group Portfolio holdings

AUM $61.9B
1-Year Est. Return 29.81%
This Fund
S&P 500
This Quarter Est. Return
+5.07%
1 Year Est. Return
+29.81%
3 Year Est. Return
+93.17%
5 Year Est. Return
+119.65%
10 Year Est. Return
AUM
$64.6B
AUM Growth
+$1.37B
Cap. Flow
-$686M
Cap. Flow %
-1.06%
Top 10 Hldgs %
38.17%
Holding
995
New
43
Increased
362
Reduced
491
Closed
59

Top Buys

Rank Stock Value
1
NU icon
Nu Holdings
NU
+$36.3M
2
SCHW
Charles Schwab
SCHW
+$36.1M
3
ASND icon
Ascendis Pharma A/S
ASND
+$35.6M
4
DHR icon
Danaher
DHR
+$30.5M
5
QURE icon
uniQure
QURE
+$28.5M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$93.5M
2
MELI icon
Mercado Libre
MELI
+$86M
3
MSFT icon
Microsoft
MSFT
+$62.9M
4
AAPL icon
Apple
AAPL
+$55.6M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$48.9M

Sector Composition

Rank Sector Weight
1 Technology 32.59%
2 Healthcare 13.39%
3 Consumer Discretionary 11.41%
4 Communication Services 11.25%
5 Financials 10.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CEG icon
76
Constellation Energy
CEG
$92.1B
$150M 0.23%
425,962
-4,737
-1% -$1.72M
ZTS icon
77
Zoetis
ZTS
$32.7B
$150M 0.23%
1,188,371
+79,220
+7% +$10.3M
UBER icon
78
Uber
UBER
$145B
$149M 0.23%
1,820,397
-14,618
-0.8% -$1.32M
KLAC icon
79
KLA
KLAC
$222B
$147M 0.23%
1,206,400
-4,140
-0.3% -$486K
CDNS icon
80
Cadence Design Systems
CDNS
$91.8B
$146M 0.23%
468,074
-39,372
-8% -$12.8M
QCOM icon
81
Qualcomm
QCOM
$164B
$146M 0.23%
854,999
-10,898
-1% -$1.87M
GILD icon
82
Gilead Sciences
GILD
$165B
$146M 0.23%
1,185,676
-162,368
-12% -$19.7M
AMT icon
83
American Tower
AMT
$83.5B
$145M 0.22%
824,998
+98,347
+14% +$17.9M
NEM icon
84
Newmont
NEM
$96.2B
$144M 0.22%
1,442,071
-19,524
-1% -$1.76M
INTC icon
85
Intel
INTC
$413B
$143M 0.22%
3,878,555
-25,784
-0.7% -$974K
GM icon
86
General Motors
GM
$80.9B
$143M 0.22%
1,757,782
-31,585
-2% -$2.23M
DLR icon
87
Digital Realty Trust
DLR
$69.6B
$142M 0.22%
917,832
-17,066
-2% -$2.8M
BKNG icon
88
Booking.com
BKNG
$156B
$141M 0.22%
658,975
-4,650
-0.7% -$957K
APH icon
89
Amphenol
APH
$185B
$139M 0.21%
1,026,818
+9,538
+0.9% +$1.28M
BA icon
90
Boeing
BA
$169B
$138M 0.21%
634,212
-3,787
-0.6% -$779K
SCHW
91
Charles Schwab
SCHW
$182B
$135M 0.21%
1,346,939
+380,074
+39% +$36.1M
VTR icon
92
Ventas
VTR
$47.5B
$133M 0.21%
1,714,166
+133,243
+8% +$10.1M
NSC icon
93
Norfolk Southern
NSC
$75.4B
$132M 0.2%
455,742
+8,186
+2% +$2.37M
NXPI icon
94
NXP Semiconductors
NXPI
$60.8B
$131M 0.2%
605,523
+77,329
+15% +$16.6M
CVS icon
95
CVS Health
CVS
$135B
$131M 0.2%
1,645,029
-46,103
-3% -$3.63M
ANET icon
96
Arista Networks
ANET
$199B
$130M 0.2%
992,470
-12,557
-1% -$1.73M
PFE icon
97
Pfizer
PFE
$143B
$130M 0.2%
5,205,453
-664,801
-11% -$16.8M
MRVL icon
98
Marvell Technology
MRVL
$147B
$127M 0.2%
1,491,701
+59,685
+4% +$5.22M
DE icon
99
Deere & Co
DE
$165B
$125M 0.19%
268,986
-2,787
-1% -$1.31M
REGN icon
100
Regeneron Pharmaceuticals
REGN
$72.9B
$125M 0.19%
161,738
+10,235
+7% +$6.95M

Similar funds

Aberdeen Group's Q4 2025 Portfolio in Review

As of Q4 2025, Aberdeen Group held 995 positions worth $64.6B, up 2.2% from $63.2B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Aberdeen Group's Q4 2025 filing shows 43 new, 362 increased, 491 reduced and 59 closed positions. Its largest new stake was Praxis Precision Medicines: 134,992 shares worth $39.8M. The largest sale was Eli Lilly, an estimated $93.5M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Aberdeen Group's largest Q4 2025 buy was Praxis Precision Medicines: 134,992 shares worth $39.8M.
  • Aberdeen Group added most to Nu Holdings in Q4 2025, an estimated $36.3M increase.
  • Aberdeen Group's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $93.5M.
  • Aberdeen Group fully exited BioMarin Pharmaceuticals in Q4 2025, selling an estimated $48.9M.
  • Aberdeen Group's ten largest holdings make up 38% of its $64.6B portfolio in Q4 2025.
  • Aberdeen Group opened 43 new positions and closed 59 in Q4 2025.
  • Aberdeen Group's portfolio value rose 2.2% quarter-over-quarter to $64.6B.

Based on Aberdeen Group's 13F filing for Q4 2025, filed 16 Jan 2026.